1. Hypercholesterolemia disrupts the metabolic regulation of hematopoietic stem cell behavior, favoring the production of pro-inflammatory monocytes in patients with familial hypercholesterolemia. (December 2020) Authors: Stiekema, L.C.A.; Willemsen, L.; Prange, K.; De Winther, M.; Voermans, C.; Stroes, E.; Kroon, J. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Ldl-Cholesterol Lowering Treatment Changes Hematopoietic Stem Cell Behavior In Familial Hypercholesterolemia Patients. (August 2019) Authors: Stiekema, L.; Zeerleder, S.S.; Homburg, C.H.; Voermans, C.; Stroes, E.S.G.; Kroon, J. Journal: Atherosclerosis Issue: Volume 287(2019) Page Start: e12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗